Close Menu

NEW YORK – The US Food and Drug Administration announced Thursday that South Korean molecular diagnostic firm GeneMatrix received Emergency Use Authorization for its SARS-CoV-2 molecular test. 

The company's NeoPlex COVID-19 Detection Kit uses RT-PCR to detect SARS-CoV-2 nucleic acid from upper and lower respiratory specimens, including nasal swabs, sputum, and tracheal aspirates.

The test can be performed by high-complexity CLIA-certified laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.